AegirBio AB (AegirBio AB) Short-Term Debt : $0.19 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is AegirBio AB Short-Term Debt?

AegirBio AB's Short-Term Debt for the quarter that ended in Mar. 2024 was $0.19 Mil.

AegirBio AB's quarterly Short-Term Debt declined from Sep. 2023 ($0.06 Mil) to Dec. 2023 ($0.02 Mil) but then increased from Dec. 2023 ($0.02 Mil) to Mar. 2024 ($0.19 Mil).

AegirBio AB's annual Short-Term Debt increased from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.51 Mil) but then declined from Dec. 2022 ($0.51 Mil) to Dec. 2023 ($0.02 Mil).

AegirBio AB Short-Term Debt Historical Data

The historical data trend for AegirBio AB's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AegirBio AB Short-Term Debt Chart

AegirBio AB Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt

0.51

0.02

AegirBio AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Debt	Get a 7-Day Free Trial													0.21	0.09	0.06	0.02	0.19

AegirBio AB Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

AegirBio AB Short-Term Debt Related Terms

Thank you for viewing the detailed overview of AegirBio AB's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

AegirBio AB (AegirBio AB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AegirBio AB (GREY:AEGBF) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

AEGIR:Sweden 52Q:Germany

Address

Scheelevagen 27, Lund, SWE, SE-223 63

Website

https://www.aegirbio.com

AegirBio AB is a Swedish diagnostic company that offers tests to monitor and optimize the dosage of biological drugs via its patented technology platform. The company's products include Monator - drug monitoring of tysabri in MS, Veritope, and Magniareader.

AegirBio AB (AegirBio AB) Headlines

No Headlines